NCT01767155 2018-07-31
ZoptEC
AEterna Zentaris
Phase 3 Completed
Clinical Trials
4 trialsNCT01234519 2018-03-15
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
AEterna Zentaris
Phase 1/2 Terminated
NCT01698281 2018-02-22
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
AEterna Zentaris
Phase 2 Terminated
NCT01240629 2017-07-11
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
University of Southern California
Phase 1/2 Completed